Ningxia Zhongke Biotechnology Co., Ltd

600165

CNE000000W47

Commodity Chemicals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
1.71 ^CNY	+4.91%		+4.91%	-49.41%

Apr. 29	Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 26	Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022

April 27, 2023 at 11:49 am EDT

Ningxia Zhongke Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 679.35 million compared to CNY 246.77 million a year ago. Revenue was CNY 681.13 million compared to CNY 248.72 million a year ago.

Net loss was CNY 141.48 million compared to CNY 166.09 million a year ago. Basic loss per share from continuing operations was CNY 0.207 compared to CNY 0.243 a year ago. Diluted loss per share from continuing operations was CNY 0.207 compared to CNY 0.243 a year ago.

Latest news about Ningxia Zhongke Biotechnology Co., Ltd

Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26	CI
Chinese Securities Regulator Warns Zhongke Biotechnology Over Late Disclosure of Unit's Suspension	Apr. 03	MT
China stocks roughly flat as sentiment remains subdued; HK shares up	Apr. 02	RE
China stocks jump on strong PMI data	Apr. 01	RE
Court Orders Freezing of Zhongke Biotechnology's Bank Accounts Worth 2.6 Million Yuan	Mar. 14	MT
Benchmark Mortgage Rate Cuts Boost Chinese Stocks; Zhongke Biotechnology Jumps 5%	Feb. 20	MT
Zhongke Biotechnology's Chairman Resigns	Feb. 20	MT
Ningxia Zhongke Biotechnology Co., Ltd(XSSC:600165) dropped from S&P Global BMI Index	Dec. 18	CI
Zhongke Biotechnology Terminates Partnership With New Materials Firm	Dec. 06	MT
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Ningxia Zhongke Biotechnology Co., Ltd(XSSC:600165) added to S&P Global BMI Index	23-09-18	CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-14	CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Shouguang Jintou New Material Technology Co., Ltd. cancelled the acquisition of an unknown stake in Ningxia Zhongke Biotechnology Co., Ltd. from Shanghai Zhongneng Enterprise Development Co., Ltd.	23-03-12	CI
Zhongke Biotechnology Sees Loss Widening for 2022	23-01-31	MT
Zhongke Biotechnology Ends Agreement With Guiyuan Biotechnology	23-01-25	MT
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Shouguang Jintou New Material Technology Co., Ltd. signed a Share Transfer Intention Agreement to acquire an unknown stake in Ningxia Zhongke Biotechnology Co., Ltd. from Shanghai Zhongneng Enterprise Development Co., Ltd.	22-09-09	CI
Ningxia Xinri Hengli Steel Wire Rope Co., Ltd entered into an agreement to acquire 10% stake in Ningxia Hengli Biological New Material Co., Ltd. from Shizuishan Zhengxingcheng New Material Technology Partnership Enterprise (Limited Partnership) for CNY 106 million.	22-06-15	CI
Ningxia Xinri Hengli Steel Wire Rope Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Ningxia Xinri Hengli Steel Wire Rope Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-26	CI
Shizuishan Zhengxingcheng New Material Technology Partnership Enterprise (Limited Partnership) cancelled the acquisition of 10% stake in Ningxia Hengli Biological New Material Co., Ltd. from Ningxia Xinri Hengli Steel Wire Rope Co.,Ltd.	22-01-16	CI
Financials, consumer weigh on China A-shares as tech lifts Hang Seng	21-11-02	RE

Chart Ningxia Zhongke Biotechnology Co., Ltd

Duration

Period

Chart Ningxia Zhongke Biotechnology Co., Ltd

More charts

Company Profile

Ningxia Zhongke Biotechnology Co Ltd, formerly NINGXIA XINRI HENGLI STEEL WIRE CO. LTD., is a China-based company mainly engaged in the production and sales of coal-based activated carbon. The Company's main businesses include chemical raw materials and chemical products manufacturing. The Company's products mainly include water purification activated carbon, air purification carbon, solvent recovery carbon, catalyst carrier carbon, chemical protective carbon and mercury removal carbon. The Company is also engaged in the large-scale production of lauric acid. The Company mainly operates its businesses in the domestic market and overseas markets.

Sector

Commodity Chemicals

Calendar

2024-05-17 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Commodity Chemicals

	1st Jan change	Capi.
NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD	-49.41%	162M
AIR LIQUIDE	+3.30%	102B
SAUDI BASIC INDUSTRIES CORPORATION	-1.92%	65.53B
PT CHANDRA ASRI PACIFIC TBK	+47.62%	41.76B
WANHUA CHEMICAL GROUP CO., LTD.	+15.99%	38.66B
LYONDELLBASELL INDUSTRIES N.V.	+4.25%	32.28B
WESTLAKE CORPORATION	+8.78%	19.57B
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+12.32%	16.77B
HENGLI PETROCHEMICAL CO.,LTD.	+17.69%	15.08B
RONGSHENG PETROCHEMICAL CO., LTD.	+8.31%	14.83B

Other Commodity Chemicals